POTENT FGFR4-TARGETED ANTIBODY-DRUG CONJUGATES AND THEIR USE FOR TREATING CANCERS EXPRESSING FGFR4
Technology
E-045-2024
Patent ID
E-045-2024-0-US-01
Country
US
Application Type
Patent Status
Expired
Patent Number
Publication Number
Application Number
63/575,037
IC
NCI
Date Filed
Date Issued
Patent PDF